Savvy Updates 2/3/20:  Bio-Artificial Pancreas, Tetanus + Diabetes, Ultra Rapid Lispro, Dexcom Future, Diabetes Wearables, Eliminating Immunosuppressants, Risks at Chain Pharmacies

Savvy Updates 2/3/20: Bio-Artificial Pancreas, Tetanus + Diabetes, Ultra Rapid Lispro, Dexcom Future, Diabetes Wearables, Eliminating Immunosuppressants, Risks at Chain Pharmacies

Artificial pancreas uses refillable oxygen tank to better-produce insulin was reported by Ben Coxworth for NewAtlas.com, 28 January 2020.  Developed by Israeli-based Beta-O2 Technologies, the titanium-bodied device is known as the Bio-artificial Pancreas, or the...
Savvy Updates, 1/20/20:

Savvy Updates, 1/20/20:

Eli Lilly Unveils Another Round of Lower-Cost Insulin Products was reported by Alex Keown bor BioSpace.com, 15 January 2020.  Eli Lilly is adding additional reduced cost insulin options to patients. The Indianapolis-based company announced lower-priced versions...
Savvy Updates, 12/16/19:  FDA Approves Tandem Control-IQ, On Dexcom’s Outage, Pacific Diabetes Tech CGM/Infusion Set, Sanofi Exits Diabetes Biz, CGMs 2020, T1 Females at Higher Heart Risk, Abbott Libre Limits Data Access, Gifts for Medical Professionals?

Savvy Updates, 12/16/19: FDA Approves Tandem Control-IQ, On Dexcom’s Outage, Pacific Diabetes Tech CGM/Infusion Set, Sanofi Exits Diabetes Biz, CGMs 2020, T1 Females at Higher Heart Risk, Abbott Libre Limits Data Access, Gifts for Medical Professionals?

FDA OKs Tandem Diabetes Control-IQ! was reported by Mike Hoskins for DiabetesMine.com, 13 December 2019.  Control-IQ combines Tandem’s touchscreen insulin pump with the popular Dexcom CGM (continuous glucose monitor) and a smart algorithm that not only...